LCMS-8045
Achieve a good count of the cells
Development of cell culture media and related analysis systems
HiMedia Laboratories Pvt. Ltd.
-
INDUSTRIA
Biopharmaceutical
-
PALABRA CLAVE
cell culture media, protein, media development
-
INTRODUCCIÓN SERVICIO Y PRODUCTOS
LCMS-8045, ICPMS-2030
Customer
Ms. Shraddha Mane
R&D and QC head in HiMedia Laboratories Pvt. Ltd.
*Los afiliados y los títulos del entrevistado están actualizados al momento del informe.
R&D and QC head in HiMedia Laboratories Pvt. Ltd.
URL
https://www.himedialabs.com/
Could you brief us about your organization, type of research carried out, product line, etc.?
HiMedia Laboratories Private Limited is an Indian-origin bioscience company headquartered in Mumbai, with a presence across 150 countries. It has different divisions such as Microbiology, Animal cell culture, Plant Cell Culture, Higronics, Molecular Biology, and Chemicals & Lab aids.
Animal Cell Culture division has proficiency in the development & manufacture of cell culture medium for mammalian & insect cell lines, in powdered and liquid formulations. Comprehensive design of experiments, raw material qualification, and media production using automation and customization are our strengths. We supply serum-free media for CHO, Vero, MDCK, HEK, PK-15, Vero, MRC-5, BHK cell lines, and T cells, most widely used for industrial production of therapeutic recombinant proteins and vaccines. In addition, we manufacture and supply multi-compendial biochemicals and growth factors for Cell Culture.
Could you outline the research activities carried out in your department?
Our main focus is on the development of different cell culture media which are used in various applications such as the industrial production of therapeutic recombinant proteins. Other research activities involve protein production, purification of the protein, spent media analysis, characterization of the protein, and media development used in vaccines where the main focus is to achieve a good count of the cells.
Read more
You can read more in the content below